185 related articles for article (PubMed ID: 37499728)
1. Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals.
Schaefer A; Yang B; Schroeder HA; Harit D; Humphry MS; Ravel J; Lai SK
Acta Biomater; 2023 Oct; 169():387-397. PubMed ID: 37499728
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition.
Schroeder HA; Nunn KL; Schaefer A; Henry CE; Lam F; Pauly MH; Whaley KJ; Zeitlin L; Humphrys MS; Ravel J; Lai SK
Mucosal Immunol; 2018 Sep; 11(5):1477-1486. PubMed ID: 29988116
[TBL] [Abstract][Full Text] [Related]
3. ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucus.
Schaefer A; Yang B; Schroeder HA; Harit D; Humphry MS; Zeitlin L; Whaley KJ; Ravel J; Fischer WA; Lai SK
Emerg Microbes Infect; 2024 Dec; 13(1):2352520. PubMed ID: 38713593
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
[TBL] [Abstract][Full Text] [Related]
5. Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus.
Wessler T; Chen A; McKinley SA; Cone R; Forest G; Lai SK
ACS Infect Dis; 2016 Jan; 2(1):82-92. PubMed ID: 26771004
[TBL] [Abstract][Full Text] [Related]
6. Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion.
Chen A; McKinley SA; Wang S; Shi F; Mucha PJ; Forest MG; Lai SK
Biophys J; 2014 May; 106(9):2028-36. PubMed ID: 24806935
[TBL] [Abstract][Full Text] [Related]
7. The biophysical principles underpinning muco-trapping functions of antibodies.
Schaefer A; Lai SK
Hum Vaccin Immunother; 2022 Apr; 18(2):1939605. PubMed ID: 34314289
[TBL] [Abstract][Full Text] [Related]
8. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
9. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections.
Wang YY; Kannan A; Nunn KL; Murphy MA; Subramani DB; Moench T; Cone R; Lai SK
Mucosal Immunol; 2014 Sep; 7(5):1036-44. PubMed ID: 24496316
[TBL] [Abstract][Full Text] [Related]
10. Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa.
McKinley SA; Chen A; Shi F; Wang S; Mucha PJ; Forest MG; Lai SK
PLoS One; 2014; 9(6):e100598. PubMed ID: 24967706
[TBL] [Abstract][Full Text] [Related]
11. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.
Lai SK; Wang YY; Hida K; Cone R; Hanes J
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):598-603. PubMed ID: 20018745
[TBL] [Abstract][Full Text] [Related]
13. LPS-binding IgG arrests actively motile Salmonella Typhimurium in gastrointestinal mucus.
Schroeder HA; Newby J; Schaefer A; Subramani B; Tubbs A; Gregory Forest M; Miao E; Lai SK
Mucosal Immunol; 2020 Sep; 13(5):814-823. PubMed ID: 32123309
[TBL] [Abstract][Full Text] [Related]
14. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
[TBL] [Abstract][Full Text] [Related]
15. Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.
Chen A; McKinley SA; Shi F; Wang S; Mucha PJ; Harit D; Forest MG; Lai SK
PLoS One; 2015; 10(7):e0131351. PubMed ID: 26132216
[TBL] [Abstract][Full Text] [Related]
16. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement.
Shukair SA; Allen SA; Cianci GC; Stieh DJ; Anderson MR; Baig SM; Gioia CJ; Spongberg EJ; Kauffman SM; McRaven MD; Lakougna HY; Hammond C; Kiser PF; Hope TJ
Mucosal Immunol; 2013 Mar; 6(2):427-34. PubMed ID: 22990624
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
Akapirat S; Karnasuta C; Vasan S; Rerks-Ngarm S; Pitisuttithum P; Madnote S; Savadsuk H; Rittiroongrad S; Puangkaew J; Phogat S; Tartaglia J; Sinangil F; de Souza MS; Excler JL; Kim JH; Robb ML; Michael NL; Ngauy V; O'Connell RJ; Karasavvas N;
PLoS One; 2018; 13(4):e0196397. PubMed ID: 29702672
[TBL] [Abstract][Full Text] [Related]
18. Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus.
Wang YY; Schroeder HA; Nunn KL; Woods K; Anderson DJ; Lai SK; Cone RA
PLoS One; 2016; 11(6):e0158338. PubMed ID: 27362256
[TBL] [Abstract][Full Text] [Related]
19. Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell Transmission.
van Dorsten RT; Reh L; Trkola A; Morris L; Moore PL
J Virol; 2022 Feb; 96(4):e0193421. PubMed ID: 34935437
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Mediated Immobilization of Virions in Mucus.
Jensen MA; Wang YY; Lai SK; Forest MG; McKinley SA
Bull Math Biol; 2019 Oct; 81(10):4069-4099. PubMed ID: 31468263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
